○Masayuki Tahara1,2 (1.Clinical Research Center, National Hospital Organization Utano National Hospital, Japan, 2.Department of rehabilitation, National Hospital Organization Utano National Hospital, Japan)
Session information
Symposium
[S-07] Symposium 07 Development of novel therapy for neurological diseases in Japan
Wed. May 19, 2021 2:15 PM - 4:15 PM Room 01 (ICC Kyoto 1F Main Hall)
Chair:Kuwabara Satoshi(Department of Neurology, Grduate of School, Chiba University),Matsubara Etsuro(Department of Neurology, Oita University Faculty of Medicine)
本邦における神経疾患の新規治療開発は、2004年の薬事法改正・医師主導治験開始を受けて特に2010年以降、免疫性、遺伝性、変性疾患など多くの疾患において日本からの国際発信となる治験も含めて、進歩が著しい領域である。日本における薬剤開発・臨床試験の最前線の状況を踏まえて展望・問題点を議論したい。
○Sonoko Misawa (Department of Neurology, Chiba university Graduate School of Medicine, Japan)
○Yuishin Izumi1, Ryosuke Oki2, Ryuji Kaji1,3 (1.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 2.Department of Neurology, Tokushima University Hospital, 3.Utano National Hospital, National Hospital Organization)
○Etsuro Matsubara (Department of Neurology, Faculty of Medicine, Oita University, Japan)
○Ken Sakushima (Pharmaceuticals and Medical Devices Agency, Japan)